Drugs / Panax Ginseng
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT01375114 | Oct 2011 → May 2016 overdue | cancer of unknown primary site | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
| Phase 1/2 | NCT00391833 | Apr 2004 → Oct 2005 | Alzheimer disease | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT00401089 | Dec 2002 → Dec 2006 | obesity disorder, schizoaffective disorder, schizophrenia, tardive dyskinesia | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01637168 | — | — | EMS | Withdrawn | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00103012 | Jan 2005 → Jan 2011 | — | National Institutes of Health Clinical Center (CC) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01006460 Comparator | Nov 2009 → Jul 2010 | depressive disorder | Frederiksberg University Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Panax ginseng | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01006460 ↗ |
| Known as | ginseng | “panax ginseng (commonly called ginseng)” NCT01375114 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “herbal preparation (Panax ginseng)” NCT00103012 ↗ |
| Route | Oral | “100 mg or 200 mg by oral route” NCT00401089 ↗ |